Please login to the form below
Roche, J&J and Novartis in hepatitis C diagnostics tie-up
Roche signs licensing agreements for Hepatitis C immunodiagnostics with J&J subsidiary Ortho-Clinical Diagnostics and Novartis
Swiss-based pharmaceutical group Roche has signed licensing agreements for Hepatitis C immunodiagnostics with J&J subsidiary Ortho-Clinical Diagnostics and Swiss-headquartered Novartis.
Roche, Ortho-Clinical and Novartis also agreed to settle all litigation related to licensed patents.
Roche will receive a worldwide royalty-bearing license under the deal, according to a Roche statement. Financial terms were not disclosed.
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
- Senior Account Director - Med Comms Agency
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
-
SENIOR MEDICAL WRITER
-
Salary TBC
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
- First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%
- Pfizer/BioNTech to develop a booster dose for their COVID-19 vaccine
- AZ/Oxford University vaccine shows 82.4% efficacy with extended dosing schedule
- Sinovac’s COVID-19 vaccine appears safe in older adults
- bluebird bio posts modest Q4 revenue growth as it continues investigation into troubled LentiGlobin
- Pfizer, BioNTech temporarily slow down shipments of COVID-19 vaccine to EU
- Bedrock’s strong start to 2021
- 4 ways to recruit Alzheimer’s disease patients for your clinical trial
- Enabling Patient-Focused Research Through Virtual Clinical Trials
- Innovative Approaches to Managing Mental Health Conditions
- Newcells Biotech secures over £5m for 3D tissue models
- FDA briefing document backs J&J’s one-dose COVID-19 vaccine
PMHub
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...
Latest intelligence
- 4 ways to recruit Alzheimer’s disease patients for your clinical trial
- What key things do you need to remember to reach patients living with Alzheimer’s disease?...
- Integrating competitive intelligence into business development, licensing and M&A strategy
- The advantages of partnering with a competitive intelligence or knowledge management team...
- Reaching patients and HCPs during the pandemic
- COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...
Quick links
Infographics
